Clozapine-related neutropenia and agranulocytosis in Korea: 2025 update for rethinking the role of monitoring system
Therapeutic Advances in Psychopharmacology · 2026-04 · 16
DOI: 10.1177/20451253261440341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 12.04.2026. Verfasst von Nuree Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Gyeongsang National University Hospital, Jinju, Republic of Korea. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: orea Health Industry Development Institute.
Abstract (Originalsprache)
Background
In February 2025, the FDA ended the mandatory Risk Evaluation and Mitigation Strategy requirements for clozapine. Korea continues mandatory hematologic testing under the Clozapine Patient Monitoring System (CPMS), yet no nationwide updates have been reported since 2006.
Objectives
This study aimed to provide contemporary real-world evidence on the incidence, timing, and clinical outcomes of clozapine-associated neutropenia and agranulocytosis in Korea, and to evaluate adherence to monitoring regulations, to inform potential revision of the national CPMS.
Design
A retrospective, multicenter cohort study was conducted using anonymized electronic medical records from two Korean tertiary hospitals between 2000 and 2023.
Methods
Patients with schizophrenia spectrum disorders who had newly initiated clozapine were included. Absolute neutrophil count (ANC) data were used to identify neutropenia (ANC < 1500/μL), moderate neutropenia (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Gyeongsang National University Hospital, Jinju, Republic of Korea.
- Department of Psychiatry, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
- Department of Psychiatry, Kyungpook National University Hospital, Daegu, Republic of Korea.
- Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Psychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Psychiatry, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea.
ORCID-Profile: Nuree Kang, Jeong Hoon Lee, Se Hyun Kim
Förderung
- orea Health Industry Development Institute
Zitieren
APA
Kang, N., Jang, J. S., Joo, S. W., Lee, J. H., Jeong, J. H., Kim, M., Ahn, Y. M., Kwon, J. S., Kim, Y. S., Lee, J. S., & Kim, S. H. (2026). Clozapine-related neutropenia and agranulocytosis in Korea: 2025 update for rethinking the role of monitoring system. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261440341
Vancouver
Kang N, Jang JS, Joo SW, Lee JH, Jeong JH, Kim M, et al. Clozapine-related neutropenia and agranulocytosis in Korea: 2025 update for rethinking the role of monitoring system. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261440341
BibTeX
@article{Kang2026,
author = {Kang, Nuree and Jang, Ji Seon and Joo, Sung Woo and Lee, Jeong Hoon and Jeong, Jae Hoon and Kim, Minah and Ahn, Yong Min and Kwon, Jun Soo and Kim, Yong Sik and Lee, Jung Sun and Kim, Se Hyun},
title = {Clozapine-related neutropenia and agranulocytosis in Korea: 2025 update for rethinking the role of monitoring system},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2026},
volume = {16},
doi = {10.1177/20451253261440341}
}
EUVIMED